This may be because: (1) it is necessary to have both α7- and α9-containing nAChRs in order to ensure sufficient target cell activation; or (2) GBM cells express heteropentameric α7α9-containing nAChRs which are mainly responsible for the effects of nicotine and choline. Here, IGKV1D-22 is linked to glioblastoma.